ARCHIVES

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000

NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation

November 13, 1992